DEBA PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
DEBA PHARMA
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€2.1m
2024 · €1.8m+€286,895
Equity
€6.2m
2024 · €6.0m+€238,156
Cash
€1.3m
2024 · €2.3m-€912,527
Balance sheet total
€6.6m
2024 · €6.4m+€205,921
Largest movements
Assets
- Cash -€912,527
down €912,527 (-40.5%), from €2.3m to €1.3m
mainly Contributions, distributions and other (-€1.9m) and Current investments (-€890,000)
- Current investments +€890,000
up €890,000 (+88.1%), from €1.0m to €1.9m
- Receivables within one year +€210,212
up €210,212 (+39.5%), from €532,680 to €742,892
of which Trade receivables: +€199,706
Equity and liabilities
- Reserves +€238,156
up €238,156 (+4.1%), from €5.8m to €6.1m
of which Distributable reserves: +€248,159
Income statement
- Gross operating margin +€399,396
up €399,396 (+15.9%), from €2.5m to €2.9m
- Taxes +€90,606
up €90,606 (+15.3%), from €593,551 to €684,156
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€1.8m
Gross operating margin
+€399,396
Staff costs
-€23,963
Depreciation
+€6,237
Write-downs
+€20,644
Other operating charges
-€19,990
Financial income
-€5,266
Financial charges
+€653
Taxes
-€90,606
Deferred taxes and other
-€210
Result 2025
€2.1m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€2.1m
Investment
-€1.1m
Financing
-€1.9m
Cash 2024
€2.3m
From operations (derived)
+€2.1m
Net result for the year
+€2.1m
Depreciation
+€127,698
Stocks and contracts
+€35,862
Receivables within one year
-€210,212
Deferred charges and accrued income
-€17,433
Smaller working-capital items
-€2,810
Trade debts
-€19,808
Tax, wage and social debts
+€40,382
Investment (derived)
-€1.1m
Investment in fixed assets (net)
-€164,363
Current investments
-€890,000
Financing
-€1.9m
Debts after one year
-€20,833
Current portion of long-term debt
-€29,167
Contributions, distributions and other
-€1.9m
Cash 2025
€1.3m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,361,960 | €6,567,881 | +€205,921 | +3.2% |
| Fixed assets | 21/28 | €1,218,539 | €1,255,204 | +€36,665 | +3.0% |
| Intangible fixed assets | 21 | €11,379 | €3,954 | -€7,426 | -65.3% |
| Tangible fixed assets | 22/27 | €1,207,160 | €1,251,251 | +€44,091 | +3.7% |
| Land and buildings | 22 | €1,110,665 | €1,103,322 | -€7,343 | -0.7% |
| Furniture and vehicles | 24 | €96,495 | €147,929 | +€51,434 | +53.3% |
| Current assets | 29/58 | €5,143,421 | €5,312,676 | +€169,256 | +3.3% |
| Stocks and contracts in progress | 3 | €1,327,823 | €1,291,961 | -€35,862 | -2.7% |
| Stocks | 30/36 | €1,327,823 | €1,291,961 | -€35,862 | -2.7% |
| Amounts receivable within one year | 40/41 | €532,680 | €742,892 | +€210,212 | +39.5% |
| Trade receivables | 40 | €532,680 | €732,385 | +€199,706 | +37.5% |
| Other amounts receivable | 41 | €0 | €10,507 | +€10,507 | |
| Current investments | 50/53 | €1,010,000 | €1,900,000 | +€890,000 | +88.1% |
| Cash at bank and in hand | 54/58 | €2,253,276 | €1,340,750 | -€912,527 | -40.5% |
| Deferred charges and accrued income | 490/1 | €19,641 | €37,074 | +€17,433 | +88.8% |
| Total equity and liabilities | 10/49 | €6,361,960 | €6,567,881 | +€205,921 | +3.2% |
| Equity | 10/15 | €5,961,843 | €6,199,999 | +€238,156 | +4.0% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Revaluation surpluses | 12 | €60,570 | €60,570 | = | 0.0% |
| Reserves | 13 | €5,839,273 | €6,077,429 | +€238,156 | +4.1% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €95,811 | €85,808 | -€10,003 | -10.4% |
| Distributable reserves | 133 | €5,737,261 | €5,985,421 | +€248,159 | +4.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Provisions and deferred taxes | 16 | €31,897 | €28,563 | -€3,334 | -10.5% |
| Deferred taxes | 168 | €31,897 | €28,563 | -€3,334 | -10.5% |
| Amounts payable | 17/49 | €368,220 | €339,319 | -€28,901 | -7.8% |
| Amounts payable after more than one year | 17 | €20,833 | €0 | -€20,833 | -100.0% |
| Financial debts | 170/4 | €20,833 | €0 | -€20,833 | -100.0% |
| Amounts payable within one year | 42/48 | €346,038 | €334,814 | -€11,223 | -3.2% |
| Current portion of amounts payable after more than one year | 42 | €50,000 | €20,833 | -€29,167 | -58.3% |
| Trade debts | 44 | €188,152 | €168,345 | -€19,808 | -10.5% |
| Suppliers | 440/4 | €188,152 | €168,345 | -€19,808 | -10.5% |
| Taxes, remuneration and social security | 45 | €44,078 | €84,459 | +€40,382 | +91.6% |
| Taxes | 450/3 | €41,409 | €79,949 | +€38,540 | +93.1% |
| Remuneration and social security | 454/9 | €2,669 | €4,510 | +€1,842 | +69.0% |
| Other amounts payable | 47/48 | €63,808 | €61,178 | -€2,630 | -4.1% |
| Accrued charges and deferred income | 492/3 | €1,349 | €4,504 | +€3,155 | +233.8% |
| Non-recurring operating income | 76A | €6,703 | €16,891 | +€10,188 | +152.0% |
| Remuneration, social security and pensions | 62 | €33,612 | €57,576 | +€23,963 | +71.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €133,935 | €127,698 | -€6,237 | -4.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €0 | -€20,644 | -€20,644 | |
| Other operating charges | 640/8 | €15,737 | €35,727 | +€19,990 | +127.0% |
| Gross operating margin | 9900 | €2,519,405 | €2,918,801 | +€399,396 | +15.9% |
| Operating profit (loss) | 9901 | €2,336,121 | €2,718,445 | +€382,324 | +16.4% |
| Financial income | 75/76B | €67,195 | €61,929 | -€5,266 | -7.8% |
| Recurring financial income | 75 | €67,195 | €61,929 | -€5,266 | -7.8% |
| Financial charges | 65/66B | €2,048 | €1,395 | -€653 | -31.9% |
| Recurring financial charges | 65 | €2,048 | €1,395 | -€653 | -31.9% |
| Profit (loss) for the period before taxes | 9903 | €2,401,267 | €2,778,978 | +€377,710 | +15.7% |
| Transfer from deferred taxes | 780 | €3,544 | €3,334 | -€210 | -5.9% |
| Income taxes | 67/77 | €593,551 | €684,156 | +€90,606 | +15.3% |
| Profit (loss) for the period | 9904 | €1,811,261 | €2,098,156 | +€286,895 | +15.8% |
| Transfer from tax-exempt reserves | 789 | €10,632 | €10,003 | -€629 | -5.9% |
| Profit (loss) for the period to be appropriated | 9905 | €1,821,893 | €2,108,159 | +€286,266 | +15.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.